Subcutaneous Suspensions
Subcutaneous Suspension is a type of parenteral drug formulation designed for injection beneath the skin, distinguished by its dispersed solid-phase drug particles in a liquid vehicle that enable sustained release and prolonged therapeutic effect.
19
Publications
791
Citations
81
Authors
46
Institutions
Publications per year
2017–2026
3
Variants
Subcutaneous Suspension
Parents
19
1–5 of 19
81
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 81
46
National Institutes of Health
Bethesda, United States
2 h-index
6 publications
118 citations
South African Institute for Medical Research
Johannesburg, South Africa
1 h-index
3 publications
129 citations
AstraZeneca (Singapore)
Singapore, Singapore
1 h-index
2 publications
40 citations
Centre Val de Loire
Tours, France
1 h-index
1 publications
20 citations

Kettering University
Flint, United States
1 h-index
2 publications
458 citations

Hospital de Sant Pau
Barcelona, Spain
1 h-index
1 publications
24 citations
Vall d'Hebron Institute of Oncology
Barcelona, Spain
1 h-index
1 publications
24 citations
Inserm
Paris, France
1 h-index
2 publications
154 citations
1–8 of 46
Repository · 2 publications · 64 citations
2
h-index
2 publications · 251 citations
2
h-index
2 publications · 84 citations
2
h-index
AAPSJ · 1 publications · 15 citations
1
h-index
1 publications · 43 citations
1
h-index
1–5